Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
Bioavailability |
92.5 |
% |
87-98 |
% |
epidural administration; |
DRUGBANK |
C Max |
1100.0 |
ng/ml |
1.1±0.2 |
mcg/ml |
|
The Pharmacological Basis of Therapeutics |
C Max |
2300.0 |
ng/ml |
2.3±0.8 |
mcg/ml |
skin/dermal; |
The Pharmacological Basis of Therapeutics |
T Max |
0.70 |
h |
0.7±0.2 |
h |
|
The Pharmacological Basis of Therapeutics |
T Max |
0.90 |
h |
0.9±0.4 |
h |
skin/dermal; |
The Pharmacological Basis of Therapeutics |
Clearance |
23.2 |
L/h |
387±107 |
ml/min |
|
DRUGBANK |
Clearance |
432.0 |
L/h |
7.2±1.6 |
L/min |
Plasma clearance; |
DRUGBANK |
Clearance |
0.38 |
L/h/kg |
5.5-7.1 |
ml/min/kg |
Average clearance; |
The Pharmacological Basis of Therapeutics |
Clearance |
0.33 |
L/h/kg |
5.5 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
0.70 |
L/kg |
0.54-0.86 |
L/kg |
Average volume of distribution; |
The Pharmacological Basis of Therapeutics |
Volume of Distribution |
0.75 |
L/kg |
0.75 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
4.2 |
h |
~4.2 |
h |
|
DRUGBANK |
Half-life |
1.8 |
h |
1.6-2.0 |
h |
different study; |
The Pharmacological Basis of Therapeutics |
Half-life |
5.5 |
h |
4-7 |
h |
epidural administration; IM,intramuscular injection; |
The Pharmacological Basis of Therapeutics |
Half-life |
2.2 |
h |
2.2 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Eliminate Route |
86.0 |
% |
86 |
% |
Urinary excretion; intravenous injection, IV; |
DRUGBANK |
Eliminate Route |
1.0 |
% |
1 |
% |
Urinary excretion; Unchanged drug; |
The Pharmacological Basis of Therapeutics |
Protein Binding |
94.0 |
% |
94 |
% |
|
DRUGBANK |
Protein Binding |
92.0 |
% |
90-94 |
% |
|
The Pharmacological Basis of Therapeutics |